Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 16/20 | 0.78 |
| ▸ | NPY1R | P25929 | 10/20 | 0.78 |
| ▸ | NPY5R | Q15761 | 9/20 | 0.78 |
| ▸ | NPY2R | P49146 | 6/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13188655 | 1.00 | NPY4R (0.78) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL370279 | 1.00 | NPY4R (0.78) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29641081 | 1.00 | NPY4R (0.78) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29641192 | 1.00 | NPY4R (0.78) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29641144 | 0.94 | NPY4R (0.80) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29641154 | 0.94 | NPY4R (0.76) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL13563459 | 0.92 | NPY4R (0.77) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL15681487 | 0.92 | NPY4R (0.77) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL3303678 | 0.92 | NPY4R (0.68) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL3993177 | 0.92 | NPY4R (0.68) | NPY4RNPY1RNPY5RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11634458-B2 | Peptides and compositions for use in cosmetics and medicine | LIPOTRUE, S.L. (ES) | 2023-04-25 | — | — | US | disclosed |
| US-20220249605-A1 | Treatment of Mood and Anxiety Disorders | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 2022-08-11 | — | — | US | disclosed |
| WO-2007065808-A2 | NEUROPEPTIDE-2 RECEPTOR-AGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2007-06-14 | — | — | WO | disclosed |